# JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

> **NCT04294771** · — · UNKNOWN · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 500000 (estimated)

## Conditions studied

- Myocarditis
- Cardiomyopathies
- Heart Diseases
- Cardiovascular Diseases
- Pericarditis
- Vasculitis

## Interventions

- **DRUG:** ICI

## Key facts

- **NCT ID:** NCT04294771
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 500000 (ESTIMATED)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294771, "JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04294771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*